Home » Clinical Trials » Diabetic Retinopathy
Clinical Trial Details
Research Study Summary
A clinical trial seeking patients for a research study for the treatment of Diabetic Retinopathy
Research Study Title
A Phase 3 Safety and Efficacy Study of Vitreosolve® for Four Ophthalmic Intravitreal Injections For Inducing Posterior Vitreous Detachment in Retinopathy Patients.
The purpose of this study is to determine the safety and efficacy of Vitreosolve® in
diabetic retinopathy patients.
To Learn more
Both Male and Female
Both Male and Female ages 50 Years and up
Subjects with a history of systemic diabetes(type I,or II)
Subject with a documented history of Non- proliferative Diabetic Retinopathy(NPDR)
Subjects with no or partial PVD at baseline exam in study eye.
Subjects with retinal pathology in the study eye other then (NPDR)
Subjects with high myopia in the study eye
Subjects who have monocular vision or central lateral vision of 20/200 or worse BCVA
in the non-study eye.
Subjects with an aphakic study eye or if pseudophakic, cataract extraction surgery
less then 6 months prior to study enrollment.
Subjects that have either vitrectomy surgery, intavitreal injections, or laser
treatments in the study eye.
Site Locations (5)
||Conde De Valenciana
NCT ID: NCT00908778
Date Last Changed: October 19, 2009
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials. Some study summaries have been edited for clarity purposes to make them easier to understand. View more study details here.